ADEL
작성자관리자
- 등록일 26-06-10
- 조회19회
- Invested Year
- 2026
- Country
- KOREA
본문
ADEL is a biotechnology company focused on developing treatments and diagnostic technologies for Alzheimer’s disease and other neurodegenerative disorders. Founded as a spin-off from the Asan Medical Center and the University of Ulsan College of Medicine, the company aims to advance innovative therapies that improve the lives of patients with dementia.
관련링크
- https://adelpharm.com/ (8회 연결)
